Actively Recruiting
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Led by University of Colorado, Denver · Updated on 2024-12-10
150
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
CONDITIONS
Official Title
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinic-based dilation and evacuation at 18 weeks gestational age or above
- Ability to speak English or Spanish
You will not qualify if you...
- Refusal to have an intravenous line (IV)
- History of coagulopathy
- Use of anticoagulant medications within the past five days
- Presence of chorioamnionitis or sepsis
- Suspected placenta accreta spectrum
- Intrauterine fetal demise
- Multiple gestation pregnancy
- Use of misoprostol for cervical preparation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Comprehensive Women's Health Center
Denver, Colorado, United States, 80230
Actively Recruiting
Research Team
M
Megan Masten, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here